Karen Kaplan covers science and medical research for the Los Angeles Times. She has been a member of the science team since 2005, including 13 years as an editor. Her first decade at The Times was spent covering technology in the Business section as both a reporter and editor. She grew up in San Diego and is a graduate of MIT and Columbia University.
Latest From This Author
Long-term data from nearly 400,000 Americans suggests that multivitamins don’t reduce the risk of premature death.
June 26, 2024
Summertime means spending time in the sun, and protecting yourself from harmful UV rays. Here are 10 myths about the pros and cons of using sunscreen.
June 25, 2024
There’s a lot riding on Americans’ food choices, including trillions of dollars in spending and our collective risk of developing a slew of chronic diseases. A new survey shows what we want to eat, and why.
June 19, 2024
After tracking hundreds of children, researchers conclude that babies who eat peanut protein early and often in their first five years of life are 71% less likely to be allergic to peanuts at age 12.
June 18, 2024
Exercise is good for you. So is a full night’s sleep. But the easiest way to boost your chances of reaching your senior years in good physical, mental and cognitive health is to turn off your TV, new research suggests.
June 14, 2024
The more people followed environmentally sustainable diets that emphasized nutrients from plants, the lower their risk of death from cancer, heart disease, Alzheimer’s disease and a variety of other causes, a new study finds.
June 10, 2024
The Allied invasion of France was one of the most consequential events of World War II. U.S. medical institutions helped make it a success, in Europe and home.
June 6, 2024
Over nearly 25 years, women who had the greatest adherence to the Mediterranean diet had a 23% lower risk of death than women who followed it the least, a new study finds.
May 31, 2024
When same-sex marriage was legalized in the U.S., opponents said it would undermine traditional marriage and destabilize families. So what actually happened?
May 30, 2024
Providing GLP-1 drugs to 19.7 million Medicare beneficiaries with obesity would cost $268 billion a year, researchers estimate in a recent study.
May 29, 2024